Advances in diagnosis and management of cancer of the esophagus

被引：26

作者：

Deboever, Nathaniel ^{[1
]}

Jones, Christopher M. ^{[2
,3
]}

Yamashita, Kohei ^{[4
]}

Ajani, Jaffer A. ^{[4
]}

Hofstetter, Wayne L. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA

[2] Univ Cambridge, Early Canc Inst, Dept Oncol, Cambridge, England

[3] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England

[4] MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2024年 / 385卷

关键词：

SQUAMOUS-CELL CARCINOMA; QUALITY-OF-LIFE; OLIGOMETASTATIC ESOPHAGOGASTRIC CANCER; GASTROESOPHAGEAL JUNCTION CANCER; EXTENDED TRANSTHORACIC RESECTION; COMBINED-MODALITY THERAPY; PHASE-III TRIAL; BARRETTS-ESOPHAGUS; OPEN-LABEL; PERIOPERATIVE CHEMOTHERAPY;

D O I：

10.1136/bmj-2023-074962

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Esophageal cancer is the seventh most common malignancy worldwide, with over 470 000 new cases diagnosed each year. Two distinct histological subtypes predominate, and should be considered biologically separate disease entities.1 These subtypes are esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). Outcomes remain poor regardless of subtype, with most patients presenting with late stage disease.2 Novel strategies to improve early detection of the respective precursor lesions, squamous dysplasia, and Barrett's esophagus offer the potential to improve outcomes. The introduction of a limited number of biologic agents, as well as immune checkpoint inhibitors, is resulting in improvements in the systemic treatment of locally advanced and metastatic esophageal cancer. These developments, coupled with improvements in minimally invasive surgical and endoscopic treatment approaches, as well as adaptive and precision radiotherapy technologies, offer the potential to improve outcomes still further. This review summarizes the latest advances in the diagnosis and management of esophageal cancer, and the developments in understanding of the biology of this disease.

引用

页数：22

共 274 条

[111] Genomic copy number predicts esophageal cancer years before transformation [J].

Killcoyne, Sarah ;

Gregson, Eleanor ;

Wedge, David C. ;

Woodcock, Dan J. ;

Eldridge, Matthew D. ;

de la Rue, Rachel ;

Miremadi, Ahmad ;

Abbas, Sujath ;

Blasko, Adrienn ;

Kosmidou, Cassandra ;

Januszewicz, Wladyslaw ;

Jenkins, Aikaterini Varanou ;

Gerstung, Moritz ;

Fitzgerald, Rebecca C. .

NATURE MEDICINE, 2020, 26 (11) :1726-+

[112] Integrated genomic characterization of oesophageal carcinoma [J].

Kim, Jihun ;

Bowlby, Reanne ;

Mungall, Andrew J. ;

Robertson, A. Gordon ;

Odze, Robert D. ;

Cherniack, Andrew D. ;

Shih, Juliann ;

Pedamallu, Chandra Sekhar ;

Cibulskis, Carrie ;

Dunford, Andrew ;

Meier, Samuel R. ;

Kim, Jaegil ;

Raphael, Benjamin J. ;

Wu, Hsin-Ta ;

Wong, Alexandra M. ;

Willis, Joseph E. ;

Bass, Adam J. ;

Derks, Sarah ;

Garman, Katherine ;

McCall, Shannon J. ;

Wiznerowicz, Maciej ;

Pantazi, Angeliki ;

Parfenov, Michael ;

Thorsson, Vesteinn ;

Shmulevich, Ilya ;

Dhankani, Varsha ;

Miller, Michael ;

Sakai, Ryo ;

Wang, Kenneth ;

Schultz, Nikolaus ;

Shen, Ronglai ;

Arora, Arshi ;

Weinhold, Nils ;

Sanchez-Vega, Francisco ;

Kelsen, David P. ;

Zhang, Julia ;

Felau, Ina ;

Demchok, John ;

Rabkin, Charles S. ;

Camargo, M. Constanza ;

Zenklusen, Jean Claude ;

Bowen, Jay ;

Leraas, Kristen ;

Lichtenberg, Tara M. ;

Curtis, Christina ;

Seoane, Jose A. ;

Ojesina, Akinyemi I. ;

Beer, David G. ;

Gulley, Margaret L. ;

Pennathur, Arjun .

NATURE, 2017, 541 (7636) :169-+

[113] Worldwide Techniques and Outcomes in Robot-assisted Minimally Invasive Esophagectomy (RAMIE) Results From the Multicenter International Registry [J].

Kingma, B. Feike ;

Grimminger, Peter P. ;

van der Sluis, Pieter C. ;

van Det, Marc J. ;

Kouwenhoven, Ewout A. ;

Chao, Yin-Kai ;

Tsai, Chun-Yi ;

Fuchs, Hans F. ;

Bruns, Christiane J. ;

Sarkaria, Inderpal S. ;

Luketich, James D. ;

Haveman, Jan W. ;

van Etten, Boudewijn ;

Chiu, Philip W. ;

Chan, Shannon M. ;

Rouanet, Philippe ;

Mourregot, Anne ;

Hoelzen, Jens-Peter ;

Sallum, Rubens A. ;

Cecconello, Ivan ;

Egberts, Jan-Hendrik ;

Benedix, Frank ;

Henegouwen, Mark I. van Berge ;

Gisbertz, Suzanne S. ;

Perez, Daniel ;

Jansen, Kristina ;

Hubka, Michal ;

Low, Donald E. ;

Biebl, Matthias ;

Pratschke, Johann ;

Turner, Paul ;

Pursnani, Kish ;

Chaudry, Asif ;

Smith, Myles ;

Mazza, Elena ;

Strignano, Paolo ;

Ruurda, Jelle P. ;

van Hillegersberg, Richard .

ANNALS OF SURGERY, 2022, 276 (05) :E386-E392

[114]

Kitagawa Y, 2019, ESOPHAGUS-TOKYO, V16, P1, DOI 10.1007/s10388-018-0641-9

[115] Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 [J].

Kitagawa, Yuko ;

Uno, Takashi ;

Oyama, Tsuneo ;

Kato, Ken ;

Kato, Hiroyuki ;

Kawakubo, Hirofumi ;

Kawamura, Osamu ;

Kusano, Motoyasu ;

Kuwano, Hiroyuki ;

Takeuchi, Hiroya ;

Toh, Yasushi ;

Doki, Yuichiro ;

Naomoto, Yoshio ;

Nemoto, Kenji ;

Booka, Eisuke ;

Matsubara, Hisahiro ;

Miyazaki, Tatsuya ;

Muto, Manabu ;

Yanagisawa, Akio ;

Yoshida, Masahiro .

ESOPHAGUS, 2019, 16 (01) :25-43

[116] Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set [J].

Klein, E. A. ;

Richards, D. ;

Cohn, A. ;

Tummala, M. ;

Lapham, R. ;

Cosgrove, D. ;

Chung, G. ;

Clement, J. ;

Gao, J. ;

Hunkapiller, N. ;

Jamshidi, A. ;

Kurtzman, K. N. ;

Seiden, M., V ;

Swanton, C. ;

Liu, M. C. .

ANNALS OF ONCOLOGY, 2021, 32 (09) :1167-1177

[117] DKN-01 and tislelizumab ± chemotherapy as a first-line (1L) and second-line (2L) investigational therapy in advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish Trial [J].

Klempner, Samuel J. ;

Chao, Joseph ;

Uronis, Hope Elizabeth ;

Sirard, Cynthia A. ;

Kagey, Michael ;

Baum, Jason ;

Song, James ;

Wang, Jin ;

Kim, In-Ho ;

Lee, Keun Wook ;

Oh, Do-Youn ;

Sonbol, Bassam Bassam ;

Wainberg, Zev A. ;

Ajani, Jaffer A. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)

[118] A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction [J].

Klevebro, F. ;

von Dobeln, G. Alexandersson ;

Wang, N. ;

Johnsen, G. ;

Jacobsen, A. -B. ;

Friesland, S. ;

Hatlevoll, I. ;

Glenjen, N. I. ;

Lind, P. ;

Tsai, J. A. ;

Lundell, L. ;

Nilsson, M. .

ANNALS OF ONCOLOGY, 2016, 27 (04) :660-667

[119] Radiofrequency ablation versus hybrid argon plasma coagulation in Barrett's esophagus: a prospective randomised trial [J].

Knabe, Mate ;

Wetzka, Jens ;

Welsch, Lukas ;

Richl, Johannes ;

Michael, Florian ;

Blosser, Sandra ;

Heilani, Myriam ;

Kronsbein, Holger ;

May, Andrea .

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2023, 37 (10) :7803-7811

[120] Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion [J].

Ko, Kyung-Pil ;

Huang, Yuanjian ;

Zhang, Shengzhe ;

Zou, Gengyi ;

Kim, Bongjun ;

Zhang, Jie ;

Jun, Sohee ;

Martin, Cecilia ;

Dunbar, Karen J. ;

Efe, Gizem ;

Rustgi, Anil K. ;

Nakagawa, Hiroshi ;

Park, Jae-, II .

GASTROENTEROLOGY, 2023, 165 (03) :613-+

← 7 8 9 10 11 12 13 14 15 16 →